Janssen and partners seek to develop treatments for dengue fever

08/29/2013 | Reuters

Johnson & Johnson's Janssen Pharmaceuticals agreed to team up with researchers from the University of Leuven in Belgium and the Wellcome Trust charity to develop treatments for dengue fever. The collaboration will focus on a series of compounds that have been shown to block dengue virus replication. The deal includes upfront payment as well as potential milestone fees and royalties.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX